lobbying_activities: 782567
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 782567 | 23ad5cb2-7e8e-40f1-b9d5-db3836889ce7 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2009 | second_quarter | MED | AACC wrote to the Agency for Healthcare Research and Quality recommending priority research areas for how the $300 million it received for comparative effectiveness under S.1, the American Recovery and Reinvestment Act of 2009, Title VIII, HHS, AHRQ, Health Research and Quality, should be allocated | Agency for Healthcare Research & Quality (AHRQ),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 10000 | 0 | 0 | 2009-07-06T15:13:09-04:00 |